coronary heart disease
11/29/2017
/
By Jhoanna Robinson
Big Pharma greed strikes again: “Life-changing” thyroid pill manufacturer spikes price by 5,000%
The National Health Service is eyeing the cessation of the incessant prescription of Liothyronine, a drug that is used to treat thyroid disorders, after its manufacturer, Oakville, Canada-based pharmaceutical company Concordia International, increased its retail price by 5,662 percent to 9.22 British pounds from 16 p per tablet. Liothyronine is used to treat hypothyroidism or […]
« Return Home
1 of 1
Popular Articles
Hep B vaccine for newborns: A dangerous mandate, a needless vaccine, driven by profit, not science
May 14, 2025
/
Lance D Johnson
Taxpayer dollars fund controversial NGO immigration programs amid trafficking allegations
May 04, 2025
/
Willow Tohi
FBI: CCP, Iran, Russia partnering with Mexican drug cartels to move fentanyl into the United States via Canada’s open northern border
May 23, 2025
/
Willow Tohi
Pharma stocks tumble after appointment of Dr. Vinay Prasad to key FDA post
May 09, 2025
/
Ramon Tomey
Mexican president rejects Trump's offer to deploy U.S. troops against cartels
May 06, 2025
/
Cassie B.
COPYRIGHT © 2017 DRUG CARTELS NEWS
Privacy Policy